Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | PTPRC | P08575 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670373 | 0.86 | EHMT2 (0.40) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL3170865 | 0.75 | GSTP1 (0.34) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL7315832 | 0.72 | ALDH1A1 (0.50) | MEN1KMT2AMAPTKDM4EPOLB | |
| SCHEMBL223194 | 0.67 | IDO1 (0.48) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL28560306 | 0.65 | MEN1 (0.41) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL3103996 | 0.64 | MEN1 (0.33) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL292030 | 0.64 | PTPN1 (0.70) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL3444897 | 0.64 | CDC25B (0.57) | MEN1KMT2AMAPTKDM4ELMNA | |
| 1,2-Naphthoquinone SCHEMBL173316 | 0.62 | PTPRC (1.00) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL7721084 | 0.62 | MEN1 (0.67) | MEN1KMT2AMAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670864-B1 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | SABIC INNOVATIVE PLASTICS IP (NL) | 2012-02-29 | — | — | EP | claimed |
| EP-1670864-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-06-21 | — | — | EP | claimed |
| US-6995266-B2 | Thermally stable anthrapyridone compositions | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | claimed |
| WO-2005033210-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2005-04-07 | — | — | US | claimed |
| EP-1670864-B1 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | SABIC INNOVATIVE PLASTICS IP (NL) | 2012-02-29 | — | — | EP | disclosed |
| CN-101475549-A | Sugar acid compound and use thereof | UNIV EAST CHINA SCIENCE & TECH (CN) | 2009-07-08 | — | — | CN | disclosed |
| EP-1670864-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060106140-A1 | Thermally stable anthrapyridone | GENERAL ELECTRIC COMPANY (US) | 2006-05-18 | — | — | US | disclosed |
| US-6995266-B2 | Thermally stable anthrapyridone compositions | GENERAL ELECTRIC COMPANY (US) | 2006-02-07 | — | — | US | disclosed |
| WO-2005033210-A2 | THERMALLY STABLE ANTHRAPYRIDONE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075500-A1 | Thermally stable anthrapyridone compositions | IK, H1-0, H1-4 | MEN1 2608/4885KMT2A 403/4885MAPT 3789/4885 |
| US-20060106140-A1 | Thermally stable anthrapyridone | IK, H1-0, H1-4 | MEN1 2830/4885KMT2A 482/4885MAPT 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.